Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 3
1983 1
1984 3
1985 3
1986 2
1987 3
1988 1
1989 4
1990 3
1992 3
1993 1
1994 3
1995 2
1996 6
1997 5
1998 6
1999 1
2000 5
2001 3
2002 3
2003 3
2004 5
2005 5
2006 4
2007 5
2008 5
2009 2
2010 5
2011 2
2012 3
2013 4
2014 5
2015 4
2016 2
2019 6
2020 5
2021 5
2022 8
2023 2
2024 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Future prospects for mitosis-targeted antitumor therapies.
Serrano-Del Valle A, Reina-Ortiz C, Benedi A, Anel A, Naval J, Marzo I. Serrano-Del Valle A, et al. Among authors: naval j. Biochem Pharmacol. 2021 Aug;190:114655. doi: 10.1016/j.bcp.2021.114655. Epub 2021 Jun 12. Biochem Pharmacol. 2021. PMID: 34129859 Free article. Review.
Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial.
Bailón L, Moltó J, Curran A, Cadiñanos J, Carlos Lopez Bernaldo de Quirós J, de Los Santos I, Ambrosioni J, Imaz A, Benet S, Suanzes P, Navarro J, González-García J, Busca C, Pérez-Latorre L, Berenguer J, García-Fraile LJ, Mejía-Abril G, Miró JM, Scévola S, Moreno S, Domingo P, Tian Y, Frankot M, Lim D, Cai Y, Vendrame E, Guo S, Wallin JJ, Geleziunas R, SenGupta D, Alarcón-Soto Y, Leal I, Aranguen A, Garcia-Garcia M, McGowan I, Brander C, Arribas JR, Mothe B; AELIX-003 Study Group. Bailón L, et al. Nat Commun. 2025 Mar 4;16(1):2146. doi: 10.1038/s41467-025-57284-w. Nat Commun. 2025. PMID: 40038256 Free PMC article. Clinical Trial.
Novel Forms of Immunomodulation for Cancer Therapy.
Serrano-Del Valle A, Naval J, Anel A, Marzo I. Serrano-Del Valle A, et al. Among authors: naval j. Trends Cancer. 2020 Jun;6(6):518-532. doi: 10.1016/j.trecan.2020.02.015. Epub 2020 Mar 31. Trends Cancer. 2020. PMID: 32460005 Review.
Apo2L/TRAIL and immune regulation.
Anel A, Bosque A, Naval J, Pineiro A, Larrad L, Alava MA, Martinez-Lorenzo MJ. Anel A, et al. Among authors: naval j. Front Biosci. 2007 Jan 1;12:2074-84. doi: 10.2741/2212. Front Biosci. 2007. PMID: 17127445 Review.
Immunogenic Cell Death and Immunotherapy of Multiple Myeloma.
Serrano-Del Valle A, Anel A, Naval J, Marzo I. Serrano-Del Valle A, et al. Among authors: naval j. Front Cell Dev Biol. 2019 Apr 16;7:50. doi: 10.3389/fcell.2019.00050. eCollection 2019. Front Cell Dev Biol. 2019. PMID: 31041312 Free PMC article. Review.
135 results